The FLEXITau platform provides detailed, quantitative, peptide-resolved molecular maps of tau for six tauopathies, as well as symptomatic and asymptomatic controls. The data identify disease-specific molecular signatures using machine learning, enabling accurate classification of tauopathies and providing critical targets for diagnostic and therapeutic development.
Read more about this post…
Credits: Source
Disclaimer
Molecular features of human pathological tau distinguish tauopathy-associated dementias – Research
Related articles